SCH 727965 in Patients With Advanced Breast and Lung Cancers (Study P04716)

Clinical trial NCT00732810 · COMPLETED

Trial details

NCT number: NCT00732810
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms Carcinoma, Non-Small-Cell Lung

Start date: 2008-07-01
Primary completion: 2011-06-01
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.